{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,6]],"date-time":"2023-10-06T07:52:34Z","timestamp":1696578754872},"reference-count":11,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2014,9,20]],"date-time":"2014-09-20T00:00:00Z","timestamp":1411171200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1007\/s12032-014-0212-4","type":"journal-article","created":{"date-parts":[[2014,9,19]],"date-time":"2014-09-19T01:05:26Z","timestamp":1411088726000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["The safety of chemotherapy for colorectal cancer patients with hepatitis C virus infection"],"prefix":"10.1007","volume":"31","author":[{"given":"Kenji","family":"Tomizawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichi","family":"Suyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuichiro","family":"Matoba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yutaka","family":"Hanaoka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeo","family":"Toda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin","family":"Moriyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihiko","family":"Shimomura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuji","family":"Miura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiromitsu","family":"Kumada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroya","family":"Kuroyanagi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshimi","family":"Takano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,9,20]]},"reference":[{"key":"212_CR1","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1159\/000076640","volume":"47","author":"J Tanaka","year":"2004","unstructured":"Tanaka J, Kumagai J, Katayama K, et al. Sex- and age-specific carriers of hepatitis B and C viruses in Japan estimated by the prevalence in the 3, 485, 648 first-time blood donors during 1995\u20132000. Intervirology. 2004;47:32\u201340.","journal-title":"Intervirology"},{"key":"212_CR2","doi-asserted-by":"crossref","first-page":"3199","DOI":"10.1200\/JCO.2010.30.0673","volume":"28","author":"AS Artz","year":"2010","unstructured":"Artz AS, Somerfield MR, Feld JJ, et al. American Society of Clinical Oncology provisional clinical opinion: chronic hepatitis B virus infection screening in patients receiving cytotoxic chemotherapy for treatment of malignant diseases. J Clin Oncol. 2010;28:3199\u2013202.","journal-title":"J Clin Oncol"},{"key":"212_CR3","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1002\/hep.23190","volume":"50","author":"AS Lok","year":"2009","unstructured":"Lok AS, McMahon BJ. Chronic hepatitis B: update 2009. Hepatology. 2009;50:661\u20132.","journal-title":"Hepatology"},{"key":"212_CR4","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.dld.2011.07.016","volume":"44","author":"N Coppola","year":"2012","unstructured":"Coppola N, Pisaturo M, Guastafierro S, et al. Increased hepatitis C viral load and reactivation of liver disease in HCV RNA-positive patients with onco-haematological disease undergoing chemotherapy. Dig Liver Dis. 2012;44:49\u201354.","journal-title":"Dig Liver Dis"},{"key":"212_CR5","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/nrclinonc.2012.1","volume":"9","author":"HA Torres","year":"2012","unstructured":"Torres HA, Davila M. Reactivation of hepatitis B virus and hepatitis C virus in patients with cancer. Nat Rev Clin Oncol. 2012;9:156\u201366.","journal-title":"Nat Rev Clin Oncol"},{"key":"212_CR6","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.clon.2003.11.015","volume":"16","author":"ME Melisko","year":"2004","unstructured":"Melisko ME, Fox R, Venook A. Reactivation of hepatitis C virus after chemotherapy for colon cancer. In Clin Oncol (R Coll Radiol). 2004;16:204\u20135.","journal-title":"In Clin Oncol (R Coll Radiol)"},{"key":"212_CR7","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1093\/oxfordjournals.annonc.a059022","volume":"5","author":"C Pree de","year":"1994","unstructured":"de Pree C, Giostra E, Galetto A, et al. Hepatitis C virus acute exacerbation during chemotherapy and radiotherapy for oesophageal carcinoma. Ann Oncol. 1994;5:861\u20132.","journal-title":"Ann Oncol"},{"key":"212_CR8","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1159\/000336904","volume":"82","author":"H Shoji","year":"2012","unstructured":"Shoji H, Hashimoto K, Kodaira M, et al. Hematologic safety of breast cancer chemotherapies in patients with hepatitis B or C virus infection. Oncology. 2012;82:228\u201333.","journal-title":"Oncology"},{"key":"212_CR9","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1200\/JCO.2007.15.4807","volume":"26","author":"CY Hsieh","year":"2008","unstructured":"Hsieh CY, Huang HH, Lin CY, et al. Rituximab-induced hepatitis C virus reactivation after spontaneous remission in diffuse large B-cell lymphoma. J Clin Oncol. 2008;26:2584\u20136.","journal-title":"J Clin Oncol"},{"key":"212_CR10","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1093\/annonc\/mdp458","volume":"21","author":"PK Morrow","year":"2010","unstructured":"Morrow PK, Tarrand JJ, Taylor SH, et al. Effects of chronic hepatitis C infection on the treatment of breast cancer patients. Ann Oncol. 2010;21:1233\u20136.","journal-title":"Ann Oncol"},{"key":"212_CR11","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.clml.2011.04.005","volume":"11","author":"A Nooka","year":"2011","unstructured":"Nooka A, Shenoy PJ, Sinha R, et al. Hepatitis C reactivation in patients who have diffuse large B-cell lymphoma treated with rituximab: a case report and review of literature. Clin Lymphoma Myeloma Leuk. 2011;11:379\u201384.","journal-title":"Clin Lymphoma Myeloma Leuk"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-014-0212-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12032-014-0212-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-014-0212-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,15]],"date-time":"2019-08-15T01:02:26Z","timestamp":1565830946000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12032-014-0212-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9,20]]},"references-count":11,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["212"],"URL":"https:\/\/doi.org\/10.1007\/s12032-014-0212-4","relation":{},"ISSN":["1357-0560","1559-131X"],"issn-type":[{"value":"1357-0560","type":"print"},{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,9,20]]},"article-number":"212"}}